Why Traditional Microbiome Testing Falls Short
Legacy lab panels and single stool samples provide only a static snapshot. They fail to capture the day-to-day microbial shifts triggered by diet, stress, environment, and lifestyle—often resulting in misleading data or missed clinical insights.
GI-Flux™ changes that. By collecting samples across multiple time points over one week, we provide a more stable, representative view of microbial activity—optimized for repeatability, accuracy, and reliability.
Clinically Built. Research Driven.
GI-Flux™ was developed in collaboration with leading microbiome researchers and physicians from institutions like UC Davis and Jessup University. It’s powered by a targeted qPCR assay, honing in on organisms with established clinical relevance—not vague associations.
These microbial targets are selected for their roles in:
- Gut permeability and inflammation
- Immune signaling and nutrient metabolism
- Brain-gut interactions tied to neurodegenerative risk
Our published research also highlights biomarkers linking leaky gut to Alzheimer’s disease, advancing the gut-brain axis from theory to clinical application.
Designed for Action, Not Curiosity
GI-Flux™ is more than data—it’s a diagnostic tool built to fit the functional and integrative medicine workflow. It delivers:
- Clinician-ready results with straightforward interpretation
- Targets chosen for their diagnostic and therapeutic relevance
- A format that empowers patient communication and informed decisions
Connected Through Intelligent Platforms
All results are integrated into the Clavion Dashboard and App, enabling:
- AI-powered interpretation in real-time
- Patient trend tracking and longitudinal views
- Seamless connection to clinical systems via HL7 FHIR and Redox
This connected system transforms raw data into meaningful care pathways—enhancing both clinical efficiency and patient engagement.
GI-Flux™ Is Just the Beginning
As part of Clavion’s precision diagnostics platform, GI-Flux™ lays the foundation for deeper insights and smarter interventions.
Coming next:
- SuperFlux™ – high-frequency, intraday microbiome sampling for acute responsiveness
- PathoScan™ – pathogen-specific detection for clinical clarity
- DeepQuest™ – a multi-system diagnostic engine combining microbiome, glycan, and blood biomarkers with AI insight
Together, these tools redefine microbiome diagnostics—making it smarter, more personal, and finally, clinically relevant.
Powered by Clavion’s proprietary assays and AI-enhanced biomarker interpretation, GI-Flux focuses on Microbes That Matter™, translating microbiome data into actionable clinical guidance, not just curiosity.